Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 17/02/2026
In
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Management group
Company website
Launch date
28/04/1995
March
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
Continuation vote
5 yearly
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 1,363.30 | 1,560.16 | 357.00 | 385.36 | -7.36 | 2 | 0.67 | Jun, Nov | 0.8 (31/03/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 27/11/2025 | 09/01/2026 | 0.700 | No | 2026 |
| 12/06/2025 | 23/07/2025 | 1.700 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Worldwide Healthcare Trust | Share price total return | 8.2 | 14.1 | -3.6 | 130.8 |
| Biotechnology & Healthcare AIC sector | Share price total return | 15.6 | 3.7 | -16.9 | 101.7 |
Scroll
Share structure
Number of shares
381,875,580
219,789,620
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 1,374,144 | 26,449,143 | 396,076,598 | 1,550,683,711 |
| Average | N/A | 1,202,230 | 1,565,520 | 1,229,730 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 4.91 | 95.83 | 1,289.99 | 5,124.16 |
| Average | N/A | 4.36 | 5.10 | 4.06 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00BN455J50 | WWH | GBX | London Stock Exchange - MAIN Boerse Berlin Chi-x Europe Limited London Stock Exchange Lusaka Stock Exchange Pink Sheets Llc (nqb) |
Scroll
Top holdings
Data as at : 31/10/2025
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 11.4 |
| Boston Scientific Corp | 9.7 |
| AstraZeneca PLC | 8.0 |
| Intuitive Surgical Inc | 6.2 |
| Edwards Lifesciences Corp | 5.6 |
| Stryker Corp | 4.8 |
| argenx SE ADR | 4.7 |
| Alnylam Pharmaceuticals Inc | 4.1 |
| Caris Life Sciences Inc | 3.0 |
| Daiichi Sankyo Co Ltd | 2.9 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.